Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Merck
McKinsey
Medtronic
Dow
Chubb
Johnson and Johnson
Healthtrust
Harvard Business School
Accenture

Generated: August 20, 2017

DrugPatentWatch Database Preview

PRESAMINE Drug Profile

« Back to Dashboard

Which patents cover Presamine, and when can generic versions of Presamine launch?

Presamine is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in PRESAMINE is imipramine hydrochloride. There are thirty-four drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the imipramine hydrochloride profile page.

Summary for Tradename: PRESAMINE

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list38
Patent Applications: see list718
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PRESAMINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
PRESAMINE
imipramine hydrochloride
TABLET;ORAL011836-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
PRESAMINE
imipramine hydrochloride
TABLET;ORAL011836-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
PRESAMINE
imipramine hydrochloride
TABLET;ORAL011836-007Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Fish and Richardson
US Army
Mallinckrodt
Dow
Covington
Colorcon
Johnson and Johnson
Boehringer Ingelheim
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot